This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Petrucelli, A.
Right arrow Articles by Goodrum, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrucelli, A.
Right arrow Articles by Goodrum, F.

 Previous Article  |  Next Article 

Journal of Virology, June 2009, p. 5615-5629, Vol. 83, No. 11
0022-538X/09/$08.00+0     doi:10.1128/JVI.01989-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Characterization of a Novel Golgi Apparatus-Localized Latency Determinant Encoded by Human Cytomegalovirus{triangledown}

Alex Petrucelli,1 Michael Rak,1 Lora Grainger,1 and Felicia Goodrum1,2*

Department of Immunobiology,1 BIO5 Institute, University of Arizona, Tucson Arizona 857212

Received 20 September 2008/ Accepted 10 March 2009

Human cytomegalovirus (HCMV) exists indefinitely in infected individuals by a yet poorly characterized latent infection in hematopoietic cells. We previously demonstrated a requirement for the putative UL138 open reading frame (ORF) in promoting a latent infection in CD34+ hematopoietic progenitor cells (HPCs) infected in vitro. In our present study, we have identified two coterminal transcripts of 2.7 and 3.6 kb and a 21-kilodalton (kDa) protein (pUL138) that are derived from the UL138 locus with early-late gene kinetics during productive infection. The UL138 transcripts and protein are detected in both fibroblasts and HPCs. A recombinant virus, FIX-UL138STOP, that synthesizes the UL138 transcripts but not the protein exhibited a partial loss-of-latency phenotype in HPCs, similar to the phenotype observed for the UL138-null recombinant virus. This finding suggests that the UL138 protein is required for latency, but it does not exclude the possibility that the UL138 transcripts or other ORFs also contribute to latency. The mechanisms by which pUL138 contributes to latency remain unknown. While the 86- and 72-kDa immediate-early proteins were not detected in HPCs infected with HCMV in vitro, pUL138 did not function directly to suppress expression from the major immediate-early promoter in reporter assays. Interestingly, pUL138 localizes to the Golgi apparatus in infected cells but is not incorporated into virus particles. The localization of pUL138 to the Golgi apparatus suggests that pUL138 contributes to HCMV latency by a novel mechanism. pUL138 is the first HCMV protein demonstrated to promote an infection with the hallmarks of latency in CD34+ HPCs.

* Corresponding author. Mailing address: Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, AZ 85721. Phone: (520) 626-7468. Fax: (520) 626-3478. E-mail: fgoodrum{at}email.arizona.edu

{triangledown} Published ahead of print on 18 March 2009.

Journal of Virology, June 2009, p. 5615-5629, Vol. 83, No. 11
0022-538X/09/$08.00+0     doi:10.1128/JVI.01989-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»